Provocative stimulation of growth hormone: a monozygotic twin study discordant for spinal cord injury
- PMID: 18092562
- PMCID: PMC2141728
- DOI: 10.1080/10790268.2007.11754579
Provocative stimulation of growth hormone: a monozygotic twin study discordant for spinal cord injury
Abstract
Background/objective: A blunted growth hormone (GH) response to provocative testing and/or low levels of plasma insulin-like growth factor-I (IGF-I) have been reported in persons with spinal cord injury (SCI). A reduction in activity of the GH-IGF-I axis may have deleterious effects on body composition and function. Provocative testing for GH stimulation was performed to determine the response in monozygotic twins that were discordant for SCI.
Methods: GH stimulation testing was performed by the administration of intravenous arginine.
Results: Nine SCI twins with paraplegia, a mean age of 39 +/- 9 years, and duration of injury of 14 +/- 9 years were studied. The twins with SCI had a significantly lower body mass index than non-SCI twins (22.5 +/- 4.0 vs 25.1 +/- 4.2 kg/m2; P < 0.05); percent fat mass was greater in the twins with SCI (30 +/- 11% vs 22 +/- 10%; P < 0.05). Baseline serum GH was correlated with percent fat only in the SCI twins. The response to GH provocative stimulation was less in the twins with SCI: peak GH response was 5.8 +/- 6.6 vs 13.0 +/- 7.3 ng/mL (P < 0.05), and sum GH response was 15.7 +/- 15.6 vs 30.2 +/- 17.3 ng/mL (P = 0.06). Although baseline serum GH was correlated with stimulated response in the SCI twins, this relationship was not found in the non-SCI twins. Adiposity was positively related to the provocative serum GH response in twins with SCI rather than negatively related, as noted in the non-SCI twins.
Conclusions: This study confirms and extends prior work that reported a reduction in stimulated GH release in persons with SCI, which was related to baseline values.
Figures



Similar articles
-
Chronic baclofen therapy improves the blunted growth hormone response to intravenous arginine in subjects with spinal cord injury.J Clin Endocrinol Metab. 1994 May;78(5):1135-8. doi: 10.1210/jcem.78.5.8175969. J Clin Endocrinol Metab. 1994. PMID: 8175969
-
Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.Eur J Endocrinol. 1998 Jul;139(1):59-71. doi: 10.1530/eje.0.1390059. Eur J Endocrinol. 1998. PMID: 9703380 Clinical Trial.
-
Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17. doi: 10.1046/j.1365-2265.2001.01275.x. Clin Endocrinol (Oxf). 2001. PMID: 11422104 Clinical Trial.
-
Growth hormone in obesity.Int J Obes Relat Metab Disord. 1999 Mar;23(3):260-71. doi: 10.1038/sj.ijo.0800807. Int J Obes Relat Metab Disord. 1999. PMID: 10193871 Review.
-
Growth hormone and cognitive function.Nat Rev Endocrinol. 2013 Jun;9(6):357-65. doi: 10.1038/nrendo.2013.78. Epub 2013 Apr 30. Nat Rev Endocrinol. 2013. PMID: 23629538 Review.
Cited by
-
Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?Int J Mol Sci. 2018 Jan 26;19(2):375. doi: 10.3390/ijms19020375. Int J Mol Sci. 2018. PMID: 29373545 Free PMC article. Review.
-
Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord.Mol Neurobiol. 2015 Oct;52(2):837-45. doi: 10.1007/s12035-015-9298-8. Epub 2015 Jul 1. Mol Neurobiol. 2015. PMID: 26126514
-
GH deficiency in patients with spinal cord injury: efficacy/safety of GH replacement, a pilot study.Endocr Connect. 2018 Oct 1;7(10):1031-1039. doi: 10.1530/EC-18-0296. Endocr Connect. 2018. PMID: 30352393 Free PMC article.
-
Low-dose baclofen therapy raised plasma insulin-like growth factor-1 concentrations, but not into the normal range in a predictable and sustained manner in men with chronic spinal cord injury.J Spinal Cord Med. 2013 Sep;36(5):476-82. doi: 10.1179/2045772312Y.0000000061. J Spinal Cord Med. 2013. PMID: 23941795 Free PMC article. Clinical Trial.
-
Risk of Low Energy Availability in National and International Level Paralympic Athletes: An Exploratory Investigation.Nutrients. 2021 Mar 18;13(3):979. doi: 10.3390/nu13030979. Nutrients. 2021. PMID: 33803566 Free PMC article.
References
-
- Spungen AM, Adkins RH, Stewart CA, et al. Factors influencing body composition in persons with spinal cord injury: A cross-sectional study. J Am Physiol. 2003;95:2398–2407. - PubMed
-
- Spungen AM, Wang J, Pierson RN, Jr, Bauman WA. Soft tissue body composition differences in monozygotic twins discordant for immobilization. J Applied Physiol. 2000;88:1310–1315. - PubMed
-
- Bauman WA, Spungen AM, Wang J, Pierson RN, Schwartz E. Relationship of fat mass and serum estradiol with lower extremity bone in persons with chronic spinal cord injury. Am J Physiol. 2006;290:E1098–E1103. - PubMed
-
- Bauman WA, Spungen AM, Flanagan S, Zhong YG, Alexander RL, Tsitouras PD. Blunted growth hormone response to intravenous arginine in subjects with a spinal cord injury. Horm Metab Res. 1994;26:152–156. - PubMed
-
- Shetty K, Sutton CH, Mattson DE, Rudman D. Hyposomatomedinemia in quadriplegic men. Am J Med Sci. 1993;305:95–100. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical